Why the study?
Transseptal access is still perceived as the last remaining barrier to completely fluoroless catheter ablations despite radiation health risks.
Does a completely fluoroless transseptal puncture and RF ablation technique safely and effectively treat arrhythmias in patients undergoing catheter ablation?
Does a completely fluoroless transseptal puncture and RF ablation technique safely and effectively treat arrhythmias in patients undergoing catheter ablation?
A completely fluoroless transseptal puncture and RF ablation technique guided by 3D mapping and ICE is safe and feasible, eliminating radiation exposure during complex electrophysiology procedures.
Answers are grounded in this paper and cite their sources.
Supports fluoroless ablation feasibility in case series; leaves open comparative efficacy versus fluoroscopy-guided procedures.
Increasing awareness of the health risks associated with the exposure of patients and staff in the catheterization laboratory to radiation has encouraged the pursuit of efforts to reduce the use of fluoroscopy during catheter ablation procedures. Although nonfluoroscopic guidance of ablation catheters has been previously described, transseptal access is still perceived as the last remaining barrier to completely fluoroless ablations. This study examined the safety and effectiveness of transseptal puncture and radiofrequency (RF) catheter ablation using a completely fluoroless approach. Three hundred eighty-two consecutive cases that had undergone completely nonfluoroscopic RF catheter ablation were evaluated. Ablation procedures were performed for atrial fibrillation, atrial flutter, atrioventricular reentry tachycardia, and pulmonary vein complex/ventricular tachycardia. Transseptal puncture and RF ablation were conducted under three-dimensional electroanatomic mapping and intracardiac echocardiography image guidance. Fluoroless transseptal puncture and catheter ablation were completed successfully in all cases, with no intraoperative complications. One patient required minimal use of fluoroscopy to visualize sheath advancement through an existing inferior vena cava filter. Procedural time was approximately 2.2 hours from transvenous access until case conclusion; transseptal access was obtained within 28 minutes of procedure initiation. Arrhythmia was found to recur in 27% of cases on average three months after the procedure. We demonstrate the safety and effectiveness of a completely fluoroless transseptal puncture and RF ablation technique that eliminates radiation exposure and enables complex electrophysiology procedures to be performed in a lead-free environment.
No takes yet. Share an insight, caveat, or question.
Salam et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: